Bisphosphonates and atypical femoral fractures: a time for reflection.
Compston
J E
JE
D019386:Alendronate / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005264:Femoral Fractures / Q000139:chemically induced* / Q000601:surgery; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate